NEW YORK, June 5 - Xerion Pharmaceuticals has agreed to license Cambridge Antibody Technology's library of human phage antibodies for use in drug discovery and functional proteomics, the companies said Tuesday.
NEW YORK, June 5 - Xerion Pharmaceuticals has agreed to license Cambridge Antibody Technology's library of human phage antibodies for use in drug discovery and functional proteomics, the companies said Tuesday.